Journals / Turkish Neurosurgery / 2018 / Cilt: 28 - Sayı: 2

Does Shunt Selection Affect the Rate of Early Shunt Complications in Neonatal Myelomeningocele-Associated Hydrocephalus? A Multi-Center Study

Pages
303–306
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Small-sized (neonatal-design or ultra-small) valves may significantly reduce the early shunt complication rate among this population

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To evaluate the effect of shunt selection on the rate of shunt revision due to early shunt complications in neonatal myelomeningocele-associated hydrocephalus.
📊
Key Findings & Data:MATERIAL and METHODS: The data of 157 neonatal myelomeningocele cases in three pediatric neurosurgery centers (Ankara University, Kocaeli University, Selcuk University) who underwent shunt surgery at the time of myelomeningocele repair between 2000 and 2014 were retrospectively analyzed.
💡
Conclusion & Impact:Small-sized (neonatal-design or ultra-small) valves may significantly reduce the early shunt complication rate among this population
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Özet

AIM: To evaluate the effect of shunt selection on the rate of shunt revision due to early shunt complications in neonatal myelomeningocele-associated hydrocephalus. MATERIAL and METHODS: The data of 157 neonatal myelomeningocele cases in three pediatric neurosurgery centers (Ankara University, Kocaeli University, Selcuk University) who underwent shunt surgery at the time of myelomeningocele repair between 2000 and 2014 were retrospectively analyzed. Clinical features of the patients, shunt types, and early shunt complications within the first three months were recorded. The patients were classified according to several features of the shunt systems, such as the valve type, valve size/contour and catheter type. RESULTS: Of all patients, 71 (45.2%) underwent early shunt revision surgery due to various complications. Mechanical complications were the most frequent cause of shunt failure, followed by infection. There was no significant difference among the valve types. Also, no significant difference was observed among the catheter types. Only valve contour/size (contoured regular/ultra-small/burr-hole/cylindrical/neonatal) seemed to significantly affect the rate of early complications. The patients with neonatal-design valves or ultrasmall valves had significantly less complications, such as poor wound-healing, wound-dehiscence, cerebrospinal fluid leak or shunt exposure. The infection rate secondary to these complications was found to be lower. CONCLUSION: Myelomeningocele patients with prominent hydrocephalus frequently have a friable skin, due to reduced macrocrania-related subcutaneous tissues. Small-sized (neonatal-design or ultra-small) valves may significantly reduce the early shunt complication rate among this population

🔖

Cite This Article

KAHİLOĞULLARI, G., ETUŞ, V., GULER, T. M., KARABAĞLI, H., ÜNLÜ, A. (2018). Does Shunt Selection Affect the Rate of Early Shunt Complications in Neonatal Myelomeningocele-Associated Hydrocephalus? A Multi-Center Study. Turkish Neurosurgery, Cilt: 28 - Sayı: 2, 303–306. https://ajindex.com/articles/404515

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Braga MHV, de Carvalho GTC, Brandao RACS, de Lima FBF, Costa BS: Early shunt complications in 46 children with hydrocephalus. Arq Neuropsiquiatr 67: 273-277, 2009 2. Chakrabortty A, Crimmins D, Hayward R, Thompson D: Toward reducing shunt placement rates in patients with myelomeningocele. J Neurosurg Pediatrics 1: 361-365, 2008 3. Clemmensen D, Rasmussen MM, Mosdal C: A retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics. Childs Nerv Syst 26: 1517-1521, 2010 4. Januschek E, Röhrig A, Kunze S, Fremerey C, Wiebe B, Messing-Jünger M: Myelomeningocele- a single institute analysis of the years 2007 to 2015. Childs Nerv Syst 16: 2016 5. Kaufman BA: Neural tube defects. Pediatr Clin N Am 51: 389- 419, 2004 6. Margaron FC, Poenaru D, Bransford R, Albright AL: Timing of ventriculoperitoneal shunt insertion following spina bifida closure in Kenya. Childs Nerv Syst 26: 1523-1528, 2010 7. Melo JRT, Pacheco P, Melo EN, Vasconcellos A, Passos RK: Clinical and ultrasonographic criteria for using ventriculoperitoneal shunts in newborns with myelomeningocele. Arq Neuropsiquiatr 73:759-763, 2015 8. Petraglia AL, Moravan MJ, Dimopoulos VG, Silberstein HJ: Ventriculosubgaleal shunting- a strategy to reduce the incidence of shunt revisions and slit ventricles: An institutional experience and review of the literature. Pediatr Neurosurg 47: 99-107, 2011 9. Radmanesh F, Nejat F, Khashab M, Ghodsi SM, Ardebili HE: Shunt complications in children with myelomeningocele: Effect of timing of shunt placement. J Neurosurg Pediatrics 3:516-520, 2009 10. Sankhla S, Khan GM: Reducing CSF shunt placement in patients with spinal myelomeningocele. J Pediatr Neurosci 4: 2-9, 2009 11. Simon TD, Whitlock KB, Cambrin JR, Kestle JR, Rosenfeld M, Dean JM, Holubkov R, Langley M, Hamblett NM: Revision surgeries are associated with significant increased risk of subsequent cerebrospinal fluid shunt infection. Pediatr Infect Dis J 31: 551–556, 2012 12. Sinha SK, Dhua A, Mathur MK, Singh S, Modi M, Ratan SK: Neural tube defect repair and ventriculoperitoneal shunting: Indications and outcome. J Neonatal Surg 1: 21, 2012 13. Talamonti G, D’Aliberti G, Collice M: Myelomeningocele: Longterm neurosurgical treatment and follow up in 202 patients. J Neurosurg 107(5 Suppl): 368-386, 2007 14. Tamburrini C, Frassanito P, Lakovaki K, Pignotti F, Rendeli C, Murolo D, Di Rocco C: Myelomeningocele: The management of the associated